Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4Artificial Intelligence in Healthcare and EducationMeta-analysis and systematic reviewsscientometrics and bibliometrics research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 20 of the 25 sources its claims cite were checked for support.

A quantitative analysis of global AI medical studies: gaps in randomized controlled trials

Open access
Wang, Qiankun, Yang, Yao, Qiu, Lingqing, Xu, Yeting, Sun, Rongjing, Xue, Peng, Qiao, Youlin·2026·npj Digital Medicine

Abstract

Medical artificial intelligence (AI) has advanced rapidly, yet a comprehensive quantitative overview of its clinical evaluation landscape remains lacking. We conducted a scoping review of 218 systematic reviews published between September 2023 and September 2024, from which 4667 primary studies were identified and classified by research stage, geography, specialty, and study design. Most studies were preclinical (88.2%, 4114/4667), while only 2.4% (113/4667) were randomized controlled trials (RCTs). Research was highly geographically concentrated: the top 10 contributing countries accounted for 75.5% of total country contributions, of which the United States and China contributed 47.5%. Among all primary studies, neoplasms (32.5%, 1518/4667) and musculoskeletal disorders (14.1%, 656/4667) were the most common, whereas digestive (38.1%, 43/113) and circulatory diseases (12.4%, 14/113) accounted for most RCTs. Among RCTs, 67.3% (76/113) were single-center, and 71.7% (81/113) did not report adherence to any reporting guideline. Overall, 82.3% (93/113) of RCTs reported favorable outcomes, although methodological concerns were common, particularly in allocation concealment and blinding. These findings indicate that medical AI research remains heavily skewed toward early-stage development, with limited high-quality clinical evidence. Strengthening trial design, multicenter collaboration, and reporting transparency will be critical to support the safe and equitable integration of AI into clinical practice.

Overview

CoChat Summary

TL;DR

This scoping review of 218 systematic reviews identified 4,667 medical AI primary studies and found a heavily preclinical evidence base: 88.2% were preclinical and only 2.4% were RCTs. RCTs were mostly single-center, often lacked reporting-guideline adherence, and had favorable outcomes but common allocation-concealment and blinding concerns.

Key findings

  • Among 4,667 primary studies, 4,114 (88.2%) were preclinical development/offline validation, 440 were early live clinical evaluation, and only 113 (2.4%) were RCTs.
  • Research was geographically concentrated: the top 10 countries accounted for 4,152/5,499 country contributions (75.5%), with the United States (1,393/5,499, 25.3%) and China (1,220/5,499, 22.2%) together contributing 47.5%.
  • Neoplasms (1,518/4,667, 32.5%) and musculoskeletal disorders (656/4,667, 14.1%) dominated overall; among RCTs, digestive (43/113, 38.1%) and circulatory diseases (14/113, 12.4%) were most common, while neoplasms were only 12/113 (10.6%).
  • RCTs were often single-center (76/113, 67.3%), had median sample size 278 (IQR 80–800), and 81/113 (71.7%) did not specify any reporting guideline; 93/113 (82.3%) reported favorable primary outcomes, but allocation concealment was low risk in only 28/113 (24.8%) and blinding of healthcare providers was probably high risk in 98/113 (86.7%).

Methods

  • Scoping review following PRISMA-ScR, prospectively registered on OSF. A two-stage search first identified systematic reviews of medical AI in clinical settings published September 20, 2023–September 20, 2024 in PubMed, Embase, and Cochrane Library; primary studies cited in those reviews were extracted, de-duplicated, and screened, yielding 4,667 included primary studies from 2012–2024.
  • Four researchers independently charted data on research stage, ICD-11 specialty, center type, sample size, country, AI role, and RCT-specific features including design, primary endpoint, comparator, reporting standards, and primary result. RCT risk of bias was assessed with ROBUST-RCT.
  • Analyses were descriptive: counts and percentages for categorical variables, medians with interquartile ranges for continuous variables, subgroup analyses by research stage and specialty, and temporal trends; R version 4.2.2 was used.

Limitations

  • Stated: extracting primary studies partly from recent systematic reviews may introduce selection/citation bias; publication bias may underrepresent negative or non-significant studies and overestimate favorable RCT results; English-language restriction may introduce language bias; categorization of reasons for non-favorable RCT outcomes relied on authors’ self-reported explanations and may be subjective; systematic-review lag and the time restriction may miss very recent research. The authors note the design likely underestimates total eligible studies more than RCTs, so the reported RCT proportion is likely conservative.
  • Stated: the time restriction applied to the systematic-review search may narrow the scope of included primary studies.
  • Evident: the review does not report a direct primary-study search or independent quality appraisal of the 218 included systematic reviews, so the mapped landscape is conditional on those reviews’ coverage and eligibility decisions; risk-of-bias assessment was performed only for RCTs, leaving methodological quality of the non-RCT majority uncharacterized.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-026-02698-z

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 Valid · 0 Not valid · 2 Not checked · 111 Own results and interpretations

76 more claims

Create a free account to see all 123 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. Longhurst, C. A., Singh, K., Chopra, A., Atreja, A. & Brownstein, J. S. A Call for Artificial Intelligence Implementation Science Centers to Evaluate Clinical Effectiveness. 1, https://doi.org/10.1056/Alp2400223 (2024). · doi:10.1056/alp2400223

Cited by

See all 4

Metadata

Authors
Wang, Q., Yang, Y., Qiu, L., Xu, Y., Sun, R., Xue, P., & Qiao, Y.
Affiliations
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Xiamen University (CN)
Corresponding author
  • Xue, Peng
  • Qiao, Youlin
Venue
npj Digital Medicine
Published
2026-04-30
Volume
9
Issue
1
ISSN
2398-6352 (ISSN-L)
OpenAlex
W7159600031
Cited by
4
References
39
Citations by year
2026: 4
FWCI
7.78
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82404286)
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2021-I2M-1-004)
  • Tencent Sustainable Social Value Inclusive Health Lab and through the ChongQing Tencent Sustainable Development Foundation (SD20240904145730)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
Keywords
artificial intelligence in healthcare, randomized controlled trials, research gaps, reporting guidelines, allocation concealment, blinding, methodological quality of trials, neoplasms, musculoskeletal disorders, gastrointestinal diseases, circulatory diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A quantitative analysis of global AI medical studies: gaps in randomized controlled trials. https://app.cochat.ai/papers/10.1038/s41746-026-02698-z
The paper
Wang, Q., Yang, Y., Qiu, L., Xu, Y., Sun, R., Xue, P., & Qiao, Y. (2026). A quantitative analysis of global AI medical studies: gaps in randomized controlled trials. npj Digital Medicine. https://doi.org/10.1038/s41746-026-02698-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.